IGF1R as a Key Target in High Risk, Metastatic Medulloblastoma.
Svalina MN, Kikuchi K, Abraham J, Lal S, Davare MA, Settelmeyer TP, Young MC, Peckham JL, Cho YJ, Michalek JE, Hernandez BS, Berlow NE, Jackson M, Guillaume DJ, Selden NR, Bigner DD, Nazemi KJ, Green SC, Corless CL, Gultekin S, Mansoor A, Rubin BP, Woltjer R, Keller C.
Svalina MN, et al. Among authors: green sc.
Sci Rep. 2016 Jun 3;6:27012. doi: 10.1038/srep27012.
Sci Rep. 2016.
PMID: 27255663
Free PMC article.